We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 132 results
  1. Epigenetic regulation of SMAD3 by histone methyltransferase SMYD2 promotes lung cancer metastasis

    Epigenetic alterations, especially histone methylation, are key factors in cell migration and invasion in cancer metastasis. However, in lung cancer...

    Kwangho Kim, Tae Young Ryu, ... Hyun-Soo Cho in Experimental & Molecular Medicine
    Article Open access 01 May 2023
  2. STUB1-SMYD2 Axis Regulates Drug Resistance in Glioma cells

    SET and MYND domain-containing protein 2 (SMYD2) is an important epigenetic regulator that methylates histone and non-histone proteins. The study...

    Kailing Pan, Bin Hu, ... Wenxia Xu in Journal of Molecular Neuroscience
    Article 08 August 2022
  3. Targeting SMYD2 inhibits angiogenesis and increases the efficiency of apatinib by suppressing EGFL7 in colorectal cancer

    Angiogenesis is an essential factor affecting the occurrence and development of solid tumors. SET And MYND Domain Containing 2 (SMYD2) serves as an...

    Yi Zhang, Lei Zhou, ... Jun Song in Angiogenesis
    Article 03 May 2022
  4. LINC01605, regulated by the EP300-SMYD2 complex, potentiates the binding between METTL3 and SPTBN2 in colorectal cancer

    Background

    Colorectal cancer (CC) is one of the major contributors to tumor-related death worldwide, and its main cause of death is distant...

    Meng Yue, Tao Liu, ... Lei Wang in Cancer Cell International
    Article Open access 20 September 2021
  5. The lysine methyltransferase SMYD2 is required for normal lymphocyte development and survival of hematopoietic leukemias

    Abstract

    The five membered S ET and M YND D omain-containing lysine methyltransferase (SMYD) family plays pivotal roles in development and...

    Mark A. Brown, Melissa A. Edwards, ... Haley O. Tucker in Genes & Immunity
    Article 02 March 2020
  6. Histone methyltransferase SMYD2: ubiquitous regulator of disease

    SET (Suppressor of variegation, Enhancer of Zeste, Trithorax) and MYND (Myeloid-Nervy-DEAF1) domain-containing protein 2 (SMYD2) is a protein...

    **n Yi, Xue-Jun Jiang, Ze-Min Fang in Clinical Epigenetics
    Article Open access 01 August 2019
  7. Role of Histone Methylation in Cancer: Pathobiology & Therapeutics

    Cancer is among the most common causes of death in the world. Despite the recent breakthroughs over the last few decades, further research studies...
    Devipriya Nagarajan, Sunilgowda Sunnagatta Nagaraja, Shreya Baisakhiya in Handbook of Oxidative Stress in Cancer: Therapeutic Aspects
    Living reference work entry 2022
  8. Role of Histone Methylation in Cancer: Pathobiology and Therapeutics

    Cancer is among the most common causes of death in the world. Despite the recent breakthroughs over the last few decades, further research studies...
    Devipriya Nagarajan, Sunilgowda Sunnagatta Nagaraja, Shreya Baisakhiya in Handbook of Oxidative Stress in Cancer: Therapeutic Aspects
    Reference work entry 2022
  9. Epigenetics

    Epigenetics is the study of heritable changes to the genome and gene expression patterns that are not caused by direct changes to the DNA sequence....
    Rajan Jain, Jonathan A. Epstein in Congenital Heart Diseases: The Broken Heart
    Chapter 2024
  10. APC/PIK3CA mutations and β-catenin status predict tankyrase inhibitor sensitivity of patient-derived colorectal cancer cells

    Background

    Aberrant WNT/β-catenin signaling drives carcinogenesis. Tankyrases poly(ADP-ribosyl)ate and destabilize AXINs, β-catenin repressors....

    Mingjue Chen, Tetsuo Mashima, ... Hiroyuki Seimiya in British Journal of Cancer
    Article 15 November 2023
  11. SMYD2 promoter DNA methylation is associated with abdominal aortic aneurysm (AAA) and SMYD2 expression in vascular smooth muscle cells

    Background

    Abdominal aortic aneurysm (AAA) is a deadly cardiovascular disease characterised by the gradual, irreversible dilation of the abdominal...

    Bradley J. Toghill, Athanasios Saratzis, ... Matthew J. Bown in Clinical Epigenetics
    Article Open access 02 March 2018
  12. Post-translational modifications on the retinoblastoma protein

    The retinoblastoma protein (pRb) functions as a cell cycle regulator controlling G1 to S phase transition and plays critical roles in tumour...

    Linbin Zhou, Danny Siu-Chun Ng, ... Wai Kit Chu in Journal of Biomedical Science
    Article Open access 01 June 2022
  13. Epigenetic Alterations as an Adaptive Response to Chemotherapy

    The growing field of cancer research has revealed the complex interaction between epigenetic modifications and the development of drug resistance in...
    Rubiada, Kaneez Fatima, ... Sameer Ullah Khan in Drug Resistance in Cancer: Mechanisms and Strategies
    Chapter 2024
  14. DNA Methylation in Aortic Aneurysms of Different Localizations

    Abstract—

    Aortic aneurysm (AA) is a life-threatening condition, and aortic rupture that is the complication of AA in the absence of emergency surgery...

    A. N. Kucher, S. A. Shipulina, ... M. S. Nazarenko in Russian Journal of Genetics
    Article 19 June 2024
  15. Hydrogen Sulfide can Scavenge Free Radicals to Improve Spinal Cord Injury by Inhibiting the p38MAPK/mTOR/NF-κB Signaling Pathway

    Spinal cord injury (SCI) causes irreversible cell loss and neurological dysfunctions. Presently, there is no an effective clinical treatment for SCI....

    Kexin Lin, Yong Zhang, ... Xuehong Liu in NeuroMolecular Medicine
    Article 21 June 2024
  16. Proteomic characterization of post-translational modifications in drug discovery

    Protein post-translational modifications (PTMs), which are usually enzymatically catalyzed, are major regulators of protein activity and involved in...

    Lin-hui Zhai, Kai-feng Chen, ... Min-jia Tan in Acta Pharmacologica Sinica
    Article 13 November 2022
  17. STAT3 pathway as a molecular target for resveratrol in breast cancer treatment

    Signal transducer and activator of transcription 3 (STAT3) induces breast cancer malignancy. Recent clinical and preclinical studies have...

    Zeynab Kohandel, Tahereh Farkhondeh, ... Saeed Samarghandian in Cancer Cell International
    Article Open access 06 September 2021
  18. Tumor-suppressive functions of protein lysine methyltransferases

    Protein lysine methyltransferases (PKMTs) play crucial roles in histone and nonhistone modifications, and their dysregulation has been linked to the...

    Nur Aziz, Yo Han Hong, ... Jae Youl Cho in Experimental & Molecular Medicine
    Article Open access 01 December 2023
  19. Epigenetics and beyond: targeting writers of protein lysine methylation to treat disease

    Protein lysine methylation is a crucial post-translational modification that regulates the functions of both histone and non-histone proteins....

    Kamakoti P. Bhat, H. Ümit Kaniskan, ... Or Gozani in Nature Reviews Drug Discovery
    Article 19 January 2021
  20. Epigenetic remodeling of the immune landscape in cancer: therapeutic hurdles and opportunities

    The tumor immune microenvironment represents a sophisticated ecosystem where various immune cell subtypes communicate with cancer cells and stromal...

    Feng-Ming Tien, Hsuan-Hsuan Lu, ... Hsing-Chen Tsai in Journal of Biomedical Science
    Article Open access 10 January 2023
Did you find what you were looking for? Share feedback.